Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Vaccine ; 32(24): 2851-8, 2014 May 19.
Artículo en Inglés | MEDLINE | ID: mdl-24641959

RESUMEN

BACKGROUND: The development of safe, effective, and affordable vaccines has become a global effort due to its vast impact on overall world health conditions. A brief overview of vaccine characterization techniques, especially in the area of high-resolution mass spectrometry, is presented. It is highly conceivable that the proper use of advanced technologies such as high-resolution mass spectrometry, along with the appropriate chemical and physical property evaluations, will yield tremendous in-depth scientific understanding for the characterization of vaccines in various stages of vaccine development. This work presents the physicochemical and biological characterization of cancer vaccine Racotumomab/alumina, a murine anti-idiotypic antibody that mimics N-glycolyl-GM3 gangliosides. This antibody has been tested as an anti-idiotypic cancer vaccine, adjuvated in Al(OH)3, in several clinical trials for melanoma, breast, and lung cancer. METHODS: Racotumomab was obtained from ascites fluid, transferred to fermentation in stirred tank at 10 L and followed to a scale up to 41 L. The mass spectrometry was used for the determination of intact molecule, light and heavy chains masses; amino acids sequence analysis, N- and C-terminal, glycosylation and posttranslational modifications. Also we used the DLS for the size distribution and zeta potential analysis. The biological analyses were performed in mice and chickens. RESULTS: We observed differences in glycosylation pattern, charge heterogeneity and structural stability between in vivo-produced and bioreactor-obtained Racotumomab products. Interestingly, these modifications had no significant impact on the immune responses elicited in two different animal models. CONCLUSIONS: We are demonstrated that this approach could potentially be more efficient and effective for supporting vaccine research and development.


Asunto(s)
Anticuerpos Antiidiotipos/química , Anticuerpos Monoclonales/química , Vacunas contra el Cáncer/química , Animales , Anticuerpos Monoclonales de Origen Murino , Reactores Biológicos , Pollos , Cromatografía Líquida de Alta Presión , Fermentación , Glicosilación , Espectrometría de Masas , Ratones , Oxidación-Reducción , Tamaño de la Partícula , Mapeo Peptídico , Procesamiento Proteico-Postraduccional , Tecnología Farmacéutica/métodos , Potencia de la Vacuna
2.
J Proteomics ; 71(2): 133-47, 2008 Jul 21.
Artículo en Inglés | MEDLINE | ID: mdl-18617141

RESUMEN

Proteomics and metabolomics technologies are potentially useful tool for the study of the very complex process of cell adaptation to protein-free medium. In this work, we used the iTRAQ technology to analyze different protein levels in adapted and non-adapted NS0 myeloma cell line. Several proteins with differential expression profile were characterized and quantified. Carbohydrate metabolism, protein synthesis and membrane transport were the principal pathways that change after the adaptation. Changes in lactate production rate with respect to glucose consumption rate were observed according to the changes observed by proteomic.


Asunto(s)
Técnicas de Cultivo de Célula/métodos , Mieloma Múltiple/metabolismo , Proteoma , Adaptación Fisiológica , Animales , Anticuerpos Monoclonales , Línea Celular Tumoral , Medio de Cultivo Libre de Suero , Receptores ErbB/antagonistas & inhibidores , Humanos , Insulina , Ratones , Proteómica
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA